These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6751606)

  • 41. Prediction of response to cancer chemotherapy.
    Sarosdy MF; Von Hoff DD
    Drugs; 1983 Nov; 26(5):454-9. PubMed ID: 6357700
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The human tumor stem cell assay revisited.
    Singletary SE; Umbach GE; Spitzer G; Drewinko B; Tomasovic B; Ajani J; Hug V; Blumenschein G
    Int J Cell Cloning; 1985 Mar; 3(2):116-28. PubMed ID: 3998518
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improvement of in vitro chemosensitivity assay for human solid tumors by application of a preculture using collagen matrix.
    Kitaoka A; Muraoka R; Tanigawa N
    Clin Cancer Res; 1997 Feb; 3(2):295-9. PubMed ID: 9815686
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical correlations with chemosensitivities measured in a rapid thymidine incorporation assay.
    Sondak VK; Bertelsen CA; Tanigawa N; Hildebrand-Zanki SU; Morton DL; Korn EL; Kern DH
    Cancer Res; 1984 Apr; 44(4):1725-8. PubMed ID: 6704978
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Antineoplastic agent sensitivity test by a stem cell assay. 1. Primary culture of renal cell carcinoma in a soft agar medium].
    Sakuramoto T; Miura T; Kubota Y
    Nihon Hinyokika Gakkai Zasshi; 1983 Jul; 74(7):1081-5. PubMed ID: 6663939
    [No Abstract]   [Full Text] [Related]  

  • 46. "Send this patient's tumor for culture and sensitivity".
    Von Hoff DD
    N Engl J Med; 1983 Jan; 308(3):154-5. PubMed ID: 6336821
    [No Abstract]   [Full Text] [Related]  

  • 47. [Colony formation of solid tumors in in vitro colony assay (human tumor stem cell assay)].
    Inoue K; Arakawa M; Ogawa M; Inagaki J; Horikoshi N; Ezaki K; Aiba K; Domyo M; Miyamoto H; Ikeda K
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2128-32. PubMed ID: 6764097
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Update of human tumor clonogenic assay in carcinoma of the lung].
    Kanzawa F
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1552-9. PubMed ID: 2992395
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro assays for new drug screening: comparison of a thymidine incorporation assay with the human tumor colony-forming assay.
    Hildebrand-Zanki SU; Kern DH
    Int J Cell Cloning; 1987 Sep; 5(5):421-31. PubMed ID: 3624922
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Drug sensitivity testing of gynecologic tumors using Volm's test and stem cell assay].
    Eidtmann H; Jonat W; Maass H
    Geburtshilfe Frauenheilkd; 1985 Jul; 45(7):477-81. PubMed ID: 4029587
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [An in vitro sensitivity assay for anti-cancer agents by measuring the inhibition rate of DNA synthesis (3H-thymidine uptake of cancer cells). II. Clinical study of 110 cases of breast cancer].
    Nio Y; Ohgaki K; Inamoto T; Kan N; Kodama H; Tobe T
    Nihon Geka Gakkai Zasshi; 1986 Jun; 87(6):680-96. PubMed ID: 3016495
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human tumor stem cell clonogenic assay sensitivity in malignant tumors and clinical correlation.
    Banerjee TK; Marx JJ; Spencer SK; Tiffany E
    Wis Med J; 1982 Dec; 81(12):19-22. PubMed ID: 6760565
    [No Abstract]   [Full Text] [Related]  

  • 53. Soft agar clonogenic assay for primary human renal carcinoma: in vitro chemotherapeutic drug sensitivity testing.
    Lieber MM; Kovach JS
    Invest Urol; 1981 Sep; 19(2):111-4. PubMed ID: 7275551
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Application of radioactive precursors for the evaluation of sensitivity of cancer cells to anticancer drugs.
    Ichihashi H; Kondo T; Sakakibara S; Akiyama S; Watanabe T
    Oncology; 1984; 41(2):88-95. PubMed ID: 6709278
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predicting response of human solid tumors to chemotherapy.
    Tanneberger S; Nissen E
    Cancer Treat Rev; 1983 Dec; 10(4):203-19. PubMed ID: 6362872
    [No Abstract]   [Full Text] [Related]  

  • 56. [Chemotherapy in the multi-disciplinary treatment of head and neck tumors: evaluation of a chemosensitivity test].
    Saito H
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1744-52. PubMed ID: 3729480
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictive tests and infrequent events in cancer chemotherapy.
    Rozencweig M; Staquet M
    Recent Results Cancer Res; 1984; 94():174-83. PubMed ID: 6387832
    [No Abstract]   [Full Text] [Related]  

  • 58. Biochemical short-term predictive assay: results of correlative trials in comparison to other assays.
    Kaufmann M
    Recent Results Cancer Res; 1984; 94():151-60. PubMed ID: 6387831
    [No Abstract]   [Full Text] [Related]  

  • 59. Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride with correlative in vitro human tumor clonogenic assay.
    Alberts DS; Mackel C; Pocelinko R; Salmon SE
    Cancer Res; 1982 Mar; 42(3):1170-5. PubMed ID: 7037174
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug design and testing: profiling of antiproliferative agents for cancer therapy using a cell-based methyl-[3H]-thymidine incorporation assay.
    Griffiths M; Sundaram H
    Methods Mol Biol; 2011; 731():451-65. PubMed ID: 21516428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.